Susceptibility of mouse minute virus to inactivation by heat in two cell culture media types

Biotechnology Progress

Volumn 25, Issue 3, 2009, Pages 854-860

  Schleh, Marc ^a   Romanowski, Peter ^a,b   Bhebe, Prince ^a   Zhang, Li ^a   Chinniah, Shivanthi ^a   Lawrence, Bill ^a   Bashiri, Houman ^a   Gaduh, Asri ^a   Rajurs, Viveka ^a   Rasmussen, Brian ^a   Chuck, Alice ^a   Dehghani, Houman ^a  

^a AMGEN INC   (United States)

^b Rosetta Pharmaceutics LLC   (United States)

Author keywords

High temperature short time; Media treatment; MMV; Parvovirus; Viral contamination

Indexed keywords

HIGH TEMPERATURE SHORT TIME; MEDIA TREATMENT; MMV; PARVOVIRUS; VIRAL CONTAMINATION;

ANIMAL CELL CULTURE; CELL MEMBRANES; CELLULAR MANUFACTURING; CONTAMINATION; FLEXIBLE MANUFACTURING SYSTEMS; MAMMALS;

CELL CULTURE;

ARTICLE; CHEMISTRY; CULTURE MEDIUM; DISINFECTION; DRUG CONTAMINATION; EVALUATION; HEAT; METHODOLOGY; PARVOVIRUS; PHYSIOLOGY; VIRUS INACTIVATION;

CULTURE MEDIA; DISINFECTION; DRUG CONTAMINATION; HOT TEMPERATURE; MINUTE VIRUS OF MICE; VIRUS INACTIVATION;

MAMMALIA; MINUTE VIRUS OF MICE; MIRIDAE; PARVOVIRUS;

EID: 67651083246     PISSN: 87567938     EISSN: None     Source Type: Journal    
DOI: 10.1002/btpr.181     Document Type: Article

References (13)

1. Garnick RL. Experience with viral contamination in cell culture. Dev Biol Stand. 1996;88:49-56.
2. Sofer G. Part 3a: plasma and plasma products (heat and solvent/ detergent treatments). Biopharm Intl. 2002;S15-S23.
3. Lelie PN, Reesink HW, Lucas CJ. Inactivation of 12 viruses by heating steps applied during manufacture of a hepatitis B vaccine. J Med Virol. 1987;23:297-301.
4. Siegl G, Bates RC, Berns KI, Carter BJ, Kelly DC, Kurstak E, Tattersall P. Characteristics and taxonomy of Parvoviridae. Intervirology. 1985;23:61-73.
5. Cotmore SF, Tattersall P. The autonomously replicating parvoviruses of vertebrates. Adv Virus Res. 1987;33:91-174.
6. Boschetti N, Wyss K, Mischler A, Hostettler T, Kempf C. Stability of minute virus of mice against temperature and sodium hydroxide. Biologicals. 2003;31:181-185.
7. Tattersall P, Bratton J. Reciprocal productive and restrictive virus-cell interactions of immunosuppressive and prototype strains of minute virus of mice. J Virol. 1983;46:944-955.
8. Romanowski P, Schleh M, Rajurs V, Chinniah S, Dehghani H. Variables affecting titer and long-term stability of xenotropic murine leukemia and mouse minute virus stocks. Bioprocess Int. 2008;6:44-52.
9. Charm SE, Landau S, Williams B, Horowitz B, Prince AM, Pascual D. High-temperature short-time heat inactivation of HIV and other viruses in human blood plasma. Vox Sang. 1992;62:12-20.
10. Horowitz B. Inactivation of viruses found with plasma proteins. Biotechnology. 1991;19:417-430.
11. Dorner F, Barrett PN, Eibl J. At what stage should virus inactivation be carrried out? Dev Biol Stand. 1993;81:137-143.
12. Goubran HA, Burnouf T, Radosevich M. Virucidal heat-treatment of single plasma units: a potential approach for developing countries. Haemophilia. 2000;6:597-604.
13. Sofer G. Virus inactivation in the 1990s-and into the 21st century. Part 4: culture media, biotechnology products, and vaccines. Biopharm Int. 2003;50-57.